267 related articles for article (PubMed ID: 18336699)
1. Liver and intestine transplantation in the United States, 1997-2006.
Freeman RB; Steffick DE; Guidinger MK; Farmer DG; Berg CL; Merion RM
Am J Transplant; 2008 Apr; 8(4 Pt 2):958-76. PubMed ID: 18336699
[TBL] [Abstract][Full Text] [Related]
2. Liver and intestine transplantation in the United States 1998-2007.
Berg CL; Steffick DE; Edwards EB; Heimbach JK; Magee JC; Washburn WK; Mazariegos GV
Am J Transplant; 2009 Apr; 9(4 Pt 2):907-31. PubMed ID: 19341415
[TBL] [Abstract][Full Text] [Related]
3. Liver and intestine transplantation in the United States, 1996-2005.
Pomfret EA; Fryer JP; Sima CS; Lake JR; Merion RM
Am J Transplant; 2007; 7(5 Pt 2):1376-89. PubMed ID: 17428286
[TBL] [Abstract][Full Text] [Related]
4. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
5. Liver and intestine transplantation.
Brown RS; Rush SH; Rosen HR; Langnas AN; Klintmalm GB; Hanto DW; Punch JD
Am J Transplant; 2004; 4 Suppl 9():81-92. PubMed ID: 15113357
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation in the United States.
Qiu J; Ozawa M; Terasaki PI
Clin Transpl; 2005; ():17-28. PubMed ID: 17424722
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation for hepatocellular carcinoma: the MELD impact.
Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
Fisher RA; Kulik LM; Freise CE; Lok AS; Shearon TH; Brown RS; Ghobrial RM; Fair JH; Olthoff KM; Kam I; Berg CL;
Am J Transplant; 2007 Jun; 7(6):1601-8. PubMed ID: 17511683
[TBL] [Abstract][Full Text] [Related]
9. Waiting list mortality for pediatric deceased donor liver transplantation in a Japanese living-donor-dominant program.
Kasahara M; Katono M; Schlegel A; Kubota T; Nakazato Y; Uchida H; Shimizu S; Yanagi Y; Takeda M; Fukuda A; Sakamoto S
Pediatr Transplant; 2019 Dec; 23(8):e13578. PubMed ID: 31535772
[TBL] [Abstract][Full Text] [Related]
10. Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.
Sharma P; Welch K; Hussain H; Pelletier SJ; Fontana RJ; Marrero J; Merion RM
Dig Dis Sci; 2012 Mar; 57(3):806-12. PubMed ID: 21953139
[TBL] [Abstract][Full Text] [Related]
11. Reduced priority MELD score for hepatocellular carcinoma does not adversely impact candidate survival awaiting liver transplantation.
Sharma P; Harper AM; Hernandez JL; Heffron T; Mulligan DC; Wiesner RH; Balan V
Am J Transplant; 2006 Aug; 6(8):1957-62. PubMed ID: 16771808
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
[TBL] [Abstract][Full Text] [Related]
13. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1996; ():1-14. PubMed ID: 9286555
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation in the MELD era: a single-center experience.
Sachdev M; Hernandez JL; Sharma P; Douglas DD; Byrne T; Harrison ME; Mulligan D; Moss A; Reddy K; Vargas HE; Rakela J; Balan V
Dig Dis Sci; 2006 Jun; 51(6):1070-8. PubMed ID: 16865573
[TBL] [Abstract][Full Text] [Related]
15. HEPATOCELLULAR CARCINOMA PATIENTS ARE ADVANTAGED IN THE CURRENT BRAZILIAN LIVER TRANSPLANT ALLOCATION SYSTEM. A COMPETING RISK ANALYSIS.
RodrÃguez S; Fleck AM; Mucenic M; Marroni C; Brandão A
Arq Gastroenterol; 2020; 57(1):19-23. PubMed ID: 32294731
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Wait-List Mortality Between Cholangiocarcinoma and Hepatocellular Carcinoma Liver Transplant Candidates.
Ziogas IA; Hickman LA; Matsuoka LK; Izzy M; Montenovo MI; Rega SA; Feurer ID; Alexopoulos SP
Liver Transpl; 2020 Sep; 26(9):1112-1120. PubMed ID: 32475062
[TBL] [Abstract][Full Text] [Related]
18. The impact of broader regional sharing of livers: 2-year results of "Share 35".
Edwards EB; Harper AM; Hirose R; Mulligan DC
Liver Transpl; 2016 Apr; 22(4):399-409. PubMed ID: 26890858
[TBL] [Abstract][Full Text] [Related]
19. Impact of change in the United Kingdom pediatric donor organ allocation policy for intestinal transplantation.
Giovanelli M; Gupte GL; McKiernan P; Pocock P; Beath SV; Lloyd C; Sharif K; Mayer DA; Mirza DF
Transplantation; 2009 Jun; 87(11):1695-9. PubMed ID: 19502962
[TBL] [Abstract][Full Text] [Related]
20. OPTN/SRTR 2021 Annual Data Report: Liver.
Kwong AJ; Ebel NH; Kim WR; Lake JR; Smith JM; Schladt DP; Schnellinger EM; Handarova D; Weiss S; Cafarella M; Snyder JJ; Israni AK; Kasiske BL
Am J Transplant; 2023 Feb; 23(2 Suppl 1):S178-S263. PubMed ID: 37132348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
